Both drugs come as oral tablets that are taken once per day. Truvada is available as a generic drug, while Descovy is not. This article explains the main ways that Descovy and Truvada are alike ...

New rules mandate that most insurers must now cover the cost. Apretude, Descovy, Truvada, and a generic version of Truvada—often referred to as PrEP—are approved for men at high risk of ...

The patent for branded TDF/emtricitabine (Truvada) has expired, allowing multiple manufacturers to offer inexpensive generic versions that contain the same ingredients. Branded TAF/emtricitabine ...

Gilead’s HIV blockbuster Truvada looks set to face generic competition in the US next year, a year earlier than expected, putting the bulk of the product’s $3 billion annual sales at risk.

Mark S. King’s January 10 blog post on his award-winning "My Fabulous Disease" site made me aware of a new, and troubling, ...

Gilead Sciences has said it plans to challenge patents held by the US government on the use of its HIV drug Truvada for pre-exposure prophylaxis (PrEP). In a move that will incense critics who ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.

There are three different products that are currently FDA approved for use as PrEP. These options include two, once-daily oral medications called Truvada (generic versions available), and Descovy. The ...

The federal government said Gilead failed to compensate the CDC for discovering that Truvada can prevent HIV infections. The lawsuit claimed Gilead "exaggerated" its role in developing the drug's ...